Malhar Chemicals engages in the manufacturing and development of Active Pharmaceutical Ingredients (API) and New Chemical Entities (NCE), API intermediates, Regulatory Starting Materials (RSM), Basic Starting Materials, Key Building Blocks, and Xanthine Derivatives for use in clinical testing and commercial production. In addition to process R&D, we provide stability studies, scale-up and process optimisation, process validations, and commercial manufacturing.
We strive to operate efficiently and effectively to enhance our eco-efficiency and eco-effectiveness for a minimal environmental footprint.
Annual health checkups are being done on a regular basis and providing adequate medical and financial assistance to COVID-19-infected employees, the contract workforce, and their family members.
With the vision to be the leader in safety, we are committed to developing and continually improving our safety systems and culture.
